Dexilant Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition:   Erosive EsophagitisInterventions:   Drug: Dexlansoprazole;   Drug: PlaceboSponsor:   TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition:   Gastroesophageal RefluxIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition:   Erosive EsophagitisInterventions:   Drug: Dexlansoprazole;   Drug: PlaceboSponsor:   TakedaNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition:   Gastroesophageal RefluxIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition:   Erosive EsophagitisInterventions:   Drug: Dexlansoprazole;   Drug: PlaceboSponsor:   TakedaNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition:   Gastroesophageal RefluxIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition:   Erosive EsophagitisInterventions:   Drug: Dexlansoprazole;   Drug: PlaceboSponsor:   TakedaNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition:   Gastroesophageal RefluxIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition:   Erosive EsophagitisInterventions:   Drug: Dexlansoprazole;   Drug: PlaceboSponsor:   TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials

A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition:   Gastroesophageal RefluxIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials